overview
About HAI
History
International
Advisory Council
Policy Board
Faculty Advisory
Committee
Staff
Careers
Support HAI
Contact Information
Scientific Research
Training Programs
Conferences and Events
Collaborations
News and Publications



Home
History
The history of HAI spans over 15 years. Scientists at HAI have helped pioneer the field of HIV research in Africa and continue to develop and implement prevention efforts against HIV and AIDS.

HAI Historic Timeline
1988 HAI established by Harvard University President Derek Bok, HSPH Dean Harvey Feinberg, and HMS Dean Daniel Tosteson.
1989 First meeting of the International Advisory Council.
1990 Official Partnership established with Thailand.
1992 Official Partnership established with Tanzania.
1994 HAI’s vaccine think tank series begins. This annual conference series addresses the challenge of creating HIV vaccines for worldwide use.
1994 Research Discovery: Demonstration that HIV-2 is transmitted much less efficiently than HIV-1, causes AIDS less often.
1995 Research Discovery: Demonstration that HIV-2 can partially protect against HIV-1 infection, showing for the first time in humans that vaccine protection against HIV-1 may be possible.
1996 The Botswana—Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education, a collaborative research and training initiative between the Government of the Republic of Botswana and HAI, is formed.
1998 The Enhancing Care Initiative, a five-year initiative funded by Merck and the U.S Health Resources and Services Administration, begins work with multidisciplinary teams of local experts in Brazil, Puerto Rico, Senegal, South Africa, and Thailand to enhance the care of people living with HIV and AIDS in resource-scarce countries.
1998 The National Institutes of Health's John E. Fogarty Foundation for International Health begins training program for students from developing countries at HAI.
1999 Oak Foundation Gives HAI $2.5 million for Southern African Research and Training Program.
2000 At the request of the Government of Botswana, the Ministry of Health and HAI established the KITSO AIDS Training Program ("KITSO" means "knowledge" in Setswana) in response to the expanding HIV epidemic and the lack of continuing medical education available to health professionals.
2000 Thailand adopts a chemoprophylaxis regimen identified by a Harvard trial as the national standard for AIDS treatment.
2000 Official Partnership established with Nigeria.
2000 Principle Research Scientist Yichen Lu of HAI and Ruan Li, Director of the Institute of Virology, Chinese Academy of Preventive Medicine, established joint laboratories working on AIDS vaccine research and development for China and Africa.
2000 "Africa Now!" A Leadership Summit to Define Africa Priorities for AIDS.
2001 AIDS Prevention Initiative in Nigeria (APIN) is funded by the Bill and Melinda Gates Foundation. APIN, led by Professor Phyllis Kanki, seeks to develop major HIV/AIDS prevention and intervention programs in Nigeria.
2001 Research Discovery: First infectious molecular clone of HIV-1C from an African isolate. First Simian/Human Immunodeficiency Virus (SHIV) chimera based on HIV-1C of African origin.
2001 Brazilian ECI AIDS Care Team presents research to national forum on the state of HIV and AIDS care for women in São Paulo and Santos, Brazil.
2001 Launch of KITSO Antiretroviral Therapy Course for Physicians.
2001 Dedication of the new Botswana-Harvard HIV Reference Laboratory, Gaborone, Botswana, first dedicated HIV research lab in Southern Africa.
2001 The BHP initiated a randomized trial in Botswana known as the Mashi Study ("Mashi" means "milk" in Setswana) to evaluate the effects of medication and breastfeeding on mother to infant transmission.
2002 HAI’s China Initiative, the first Chinese recipient of an AIDS grant from the US NIH, becomes component of Chinese National AIDS Program.
2002 The Tshepo Study ("Tshepo" means "hope" in Setswana) is the first large-scale research study that aims to assess the emergence of drug resistance to and the tolerability of different protease inhibitor sparing highly active anti-retroviral therapy (HAART) regimens. Funded by Secure the Future.
2003 First volunteers injected with vaccine in Phase 1 of the Botswana HIV Vaccine Trial.
2003 KITSO trains its 1000th health care worker in Botswana.
2004 KITSO trains its 3000th health care worker in Botswana.
2004 BHP helps in treating more than 11,000 HIV-infected patients in the Botswana national ARV treatment program
2004 "AIDS in Asia", a comprehensive AIDS reference book for public health and medical professionals, is published.
2004 First Roundtable on "Economic Evaluation of ARV Programs in Southern Africa" is held in KwaZulu-Natal, Sount Africa
Overview | Scientific Research | Training Programs | Conferences & Events | Collaborations | News & Publications | Search | Home

To contact us with suggestions, comments, and questions, please e-mail: hai@hsph.harvard.edu.

© Copyright 2006, President and Fellows of Harvard College